Several significant new injectable cancer drugs are now hitting the market
July 1996
Several significant new injectable cancer drugs are now hitting the market...with more on the way. The FDA is accelerating approval of important cancer drugs...similar to AIDS drugs.
Lilly is now marketing Gemzar (GEM-zar, gemcitabine), the first new drug for advanced pancreatic cancer in 30 years.
It's an alternative to 5-fluorouracil and reduces pain better.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote